After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Bio-Techne Corp is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Bio-Techne Corp is $9.79B. A total of 3.49 million shares were traded on the day, compared to an average of 2.34M shares.
In the most recent transaction, Nusse Roeland sold 17,040 shares of TECH for 56.36 per share on Aug 25 ’25. After the transaction, the Director now owns 44,559 company shares. In a previous transaction on Aug 25 ’25, BAUMGARTNER ROBERT V sold 17,040 shares at 56.21 per share. TECH shares that Director owns now total 44,863.
Among the insiders who bought shares, ROELAND NUSSE acquired of 17,040 shares on Aug 25 ’25 at a per-share price of $56.36. In another insider transaction, ROBERT V. BAUMGARTNER4731 BONI bought 17,040 shares at $56.21 per share on Aug 25 ’25.
Dividend
It is more appealing for investors to invest in companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook for the company. Bio-Techne Corp pays an annual dividend of $0.32, resulting in a dividend yield of 0.51%, and it has a price to earnings (P/E) ratio of 138.81.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, TECH has a high of $80.80 and a low of $46.01.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. TECH’s latest balance sheet shows that the firm has $247.03M in Cash & Short Term Investments as of fiscal 2022. There were $325.97M in debt and $176.02M in liabilities at the time. Its Book Value Per Share was $12.38, while its Total Shareholder’s Equity was $1.70B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TECH is Buy with a score of 4.35.
